Clinical Trials

NCT02565576 | COMPLETED | PHASE2

44 participants

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-09-29

Completion:

2017-07-31

Conditions

• Myasthenia Gravis, Generalized

Interventions

• DRUG

Results Available

NCT02554890 | COMPLETED | PHASE4

887 participants

Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2016-04-29

Completion:

2018-06-29

Conditions

• Acute Heart Failure

Interventions

• DRUG

Results Available

NCT02528071 | TERMINATED

136 participants

Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis

Study Type:

OBSERVATIONAL

Last Updated:

2021-01-05

Start Date:

2014-09-29

Completion:

2020-10-28

Conditions

• ALS (Amyotrophic Lateral Sclerosis)

Interventions

• OTHER

No Results Yet

NCT02516605 | COMPLETED | PHASE2

61 participants

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-09-09

Completion:

2018-08-02

Conditions

• Primary Biliary Cholangitis

Interventions

• DRUG

Results Available

NCT02515331 | COMPLETED | PHASE2

64 participants

Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-11-04

Completion:

2017-08-17

Conditions

• Patients, Resistant Hypertension

Interventions

• DRUG

Results Available

NCT02482428 | COMPLETED | PHASE2

88 participants

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-05-12

Completion:

2016-05-31

Conditions

• External Genital Warts

Interventions

• DRUG

Results Available

NCT02477332 | COMPLETED | PHASE2

382 participants

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-07-15

Completion:

2016-11-02

Conditions

• Chronic Spontaneous Urticaria

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT02470403 | COMPLETED | PHASE2

181 participants

Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-06-05

Completion:

2016-04-04

Conditions

• Elevated Body Mass Index

Interventions

• DRUG

Results Available

NCT02449018 | COMPLETED | PHASE2

92 participants

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-04-30

Completion:

2016-12-27

Conditions

• Chronic Obstructive Pulmonary Disease, COPD

Interventions

• DRUG

Results Available

NCT02442323 | COMPLETED | NA

50 participants

A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-08-09

Completion:

2020-08-30

Conditions

• Cancer of Pancreas

Interventions

• BEHAVIORAL

No Results Yet

NCT02404389 | COMPLETED | PHASE2

82 participants

Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-03-05

Completion:

2016-01-27

Conditions

• Actinic Keratosis

Interventions

• DRUG

Results Available

NCT02388165 | TERMINATED | PHASE2

3450 participants

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-07-02

Completion:

2019-06-26

Conditions

• Staphylococcal Vaccine

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT02333331 | COMPLETED | PHASE2

217 participants

Dose Range Finding Study of Bimagrumab in Sarcopenia

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2014-12-09

Completion:

2018-06-26

Conditions

• Sarcopenia

Interventions

• DRUG
• OTHER

Results Available

NCT02291029 | COMPLETED | PHASE2

69 participants

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2014-10-22

Completion:

2018-06-29

Conditions

• Primary Sjögren's Syndrome

Interventions

• DRUG

Results Available

NCT02268526 | COMPLETED | PHASE2

86 participants

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2015-06-02

Completion:

2016-12-07

Conditions

• HCMV

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT02267135 | COMPLETED | PHASE3

102 participants

Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2014-09-29

Completion:

2015-12-07

Conditions

• Chronic Scalp Psoriasis

Interventions

• BIOLOGICAL

Results Available

NCT02228369 | COMPLETED | PHASE1

108 participants

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2014-11-05

Completion:

2017-08-19

Conditions

• EGFR Mutation Positive Advanced Non Small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT02083991 | COMPLETED | PHASE4

224 participants

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-01-31

Completion:

2017-01-31

Conditions

• Diabetes Mellitus

Interventions

• DRUG

No Results Yet

NCT02038049 | TERMINATED | PHASE2

8 participants

A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-12-20

Completion:

2015-05-05

Conditions

• Relapse Remitting Multiple Sclerosis

Interventions

• DRUG

Results Available

NCT02029274 | TERMINATED | PHASE2

17 participants

Safety and Efficacy of BAF312 in Dermatomyositis

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-08-25

Completion:

2016-02-17

Conditions

• Active Dermatomyositis

Interventions

• DRUG

Results Available

NCT02024932 | COMPLETED | PHASE2

37 participants

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2014-02-04

Completion:

2016-04-13

Conditions

• Spinal and Bulbar Muscular Atrophy

Interventions

• DRUG

Results Available

NCT02007252 | TERMINATED | PHASE2

65 participants

ACZ885 for the Treatment of Abdominal Aortic Aneurysm

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-12-31

Completion:

2015-10-31

Conditions

• Abdominal Aortic Aneurysm (AAA)

Interventions

• DRUG

Results Available

NCT01994850 | COMPLETED | PHASE1/PHASE2

32 participants

Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-11-30

Completion:

2017-08-31

Conditions

• CD30 Positive Primary Mediastinal Large B-cell Lymphoma
• CD30-Positive Diffuse Large B-Cell Lymphoma
• CD30-Positive Gray Zone Lymphoma

Interventions

• DRUG

Results Available

NCT01930162 | COMPLETED | PHASE2

9 participants

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2014-10-07

Completion:

2016-08-29

Conditions

• Single Umbilical Cord Blood Transplantation
• Non-myeloablative Conditioning
• Acute Lymphocytic Leukemia
• Myelodysplastic Syndrome
• Non-Hodgkin's Lymphoma
• Multiple Myeloma
• Chronic Lymphocytic Leukemia

Interventions

• DRUG

Results Available

NCT01895881 | WITHDRAWN | PHASE2

0 participants

Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-04-30

Completion:

2018-12-31

Conditions

• Cerebral Aneurysm
• Menopause
• Treatment

Interventions

• DRUG

No Results Yet

NCT01882985 | COMPLETED | PHASE2

14 participants

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2010-12-31

Completion:

2016-10-31

Conditions

• Adenocarcinoma of the Prostate
• Recurrent Prostate Cancer
• Stage I Prostate Cancer
• Stage IIA Prostate Cancer
• Stage IIB Prostate Cancer
• Stage III Prostate Cancer

Interventions

• DRUG
• DIETARY_SUPPLEMENT

Results Available

NCT01870739 | COMPLETED | PHASE2

115 participants

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-10-31

Completion:

2015-06-30

Conditions

• Hypertension

Interventions

• DRUG
• OTHER

Results Available

NCT01842815 | COMPLETED | NA

20 participants

Evaluation of the 755nm Alexandrite for Unwanted Tattoos

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-03-31

Completion:

2015-12-31

Conditions

• Unwanted, Non Cosmetic, Tattoos

Interventions

• DEVICE

Results Available

NCT01834846 | UNKNOWN | NA

100 participants

Impact of Perivascular Tissue on Endothelial Function in Coronary Artery Bypass Grafting

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-05-31

Completion:

2016-12-31

Conditions

• Myocardial Ischemia

Interventions

• PROCEDURE

No Results Yet

NCT01820572 | COMPLETED | PHASE3

446 participants

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-03-27

Completion:

2019-10-24

Conditions

• Kidney Transplantation

Interventions

• DRUG

Results Available

NCT01801917 | TERMINATED | PHASE2

14 participants

Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-04-24

Completion:

2016-08-05

Conditions

• Polymyositis

Interventions

• DRUG

Results Available

NCT01774279 | UNKNOWN

350 participants

interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)

Study Type:

OBSERVATIONAL

Last Updated:

2021-01-05

Start Date:

2013-06-30

Completion:

2025-02-28

Conditions

• Anaplastic Thyroid Cancer

Interventions

• OTHER

No Results Yet

NCT01765920 | COMPLETED | PHASE3

342 participants

Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2012-12-31

Completion:

2014-12-31

Conditions

• Acute Upper Respiratory Tract Infections

Interventions

• DRUG

Results Available

NCT01732874 | COMPLETED | PHASE1/PHASE2

27 participants

DHA Supplementation for Lactating Mothers

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-05-31

Completion:

2018-07-16

Conditions

• Docosohexaenoic Acid Supplementation of Mothers to

Interventions

• DRUG

Results Available

NCT01702064 | COMPLETED | PHASE1

11 participants

Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2013-02-21

Completion:

2016-10-17

Conditions

• Chronic Phase Chronic Myeloid Leukemia

Interventions

• DRUG

No Results Yet

NCT01652976 | COMPLETED | PHASE2

44 participants

Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2012-07-31

Completion:

2018-02-28

Conditions

• Pancreatic Cancer Metastatic

Interventions

• DRUG

Results Available

NCT01643850 | COMPLETED | PHASE2

36 participants

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2012-04-23

Completion:

2017-12-07

Conditions

• Pigmented Villonodular Synovitis
• PVNS
• Giant Cell Tumor of the Tendon Sheath
• GCCTS
• Tenosynovial Giant Cell Tumor Localized or Diffused Type
• GCTS

Interventions

• DRUG

Results Available

NCT01623596 | COMPLETED | PHASE4

881 participants

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2012-06-08

Completion:

2015-07-13

Conditions

• Relapsing Remitting Multiple Sclerosis

Interventions

• DRUG

Results Available

NCT01578499 | COMPLETED | PHASE3

131 participants

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2012-06-11

Completion:

2016-05-31

Conditions

• Primary Cutaneous Anaplastic Large Cell Lymphoma
• Mycosis Fungoides
• Cutaneous T-Cell Lymphoma

Interventions

• DRUG

Results Available

NCT01527500 | COMPLETED | PHASE2

158 participants

Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)

Study Type:

INTERVENTIONAL

Last Updated:

2021-01-05

Start Date:

2012-01-25

Completion:

2015-06-24

Conditions

• Geographic Atrophy
• Age-related Macular Degeneration

Interventions

• DRUG

Results Available